These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 5577288)

  • 1. [A drug for therapy of essential hypertension].
    Meoni S; Costa S; Rossi R
    Minerva Med; 1971 Apr; 62(30):1581-7. PubMed ID: 5577288
    [No Abstract]   [Full Text] [Related]  

  • 2. [A drug for the treatment of essential hypertension].
    Meoni S; Costa S; Rossi R
    Minerva Med; 1971 Apr; 62(30):1581-7. PubMed ID: 5556771
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the therapy of hypertension with an imidazoline derivative].
    Krause W; Krämer D; Grünitz B
    Med Klin; 1969 Jul; 64(28):1274-6. PubMed ID: 5799785
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety and efficacy of moxonidine in mild to moderate hypertension.
    Jain S; Malhotra P; Kumari S; Varma S
    J Assoc Physicians India; 2001 Aug; 49():829-30. PubMed ID: 11837474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of elemental arterial hypertension by a new imidazole derivative].
    Valdés EF; Mendoza R; Gonçalves N
    Prensa Med Argent; 1967 Nov; 54(37):2068-71. PubMed ID: 5613692
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of catapresan in the treatment of arterial hypertension].
    Teodorescu P; Cîmpeanu A
    Med Interna (Bucur); 1970 Dec; 22(12):1475-86. PubMed ID: 5502468
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of imidazoline derivatives in patients with arterial hypertension].
    Ol'binskaia LI; Enikeeva NB; Sinopal'nikov AI
    Klin Med (Mosk); 1980 Jul; 58(7):28-33. PubMed ID: 7289460
    [No Abstract]   [Full Text] [Related]  

  • 8. Trial of a new hypotensive drug--clonidine ("catapres").
    Trinker FR; Barnett AJ
    Med J Aust; 1970 Oct; 2(15):975-8. PubMed ID: 4920641
    [No Abstract]   [Full Text] [Related]  

  • 9. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B
    Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug therapy of hypertension].
    Popov NG
    Dtsch Med J; 1967 Sep; 18(18):537-42. PubMed ID: 5613629
    [No Abstract]   [Full Text] [Related]  

  • 11. [1st results with a new antihypertensive agent; or imidazoline hydrochloride (ST 155)].
    Faerchtein I; Francisco Roque A; Kastansky I; Kac LB
    Hospital (Rio J); 1969 May; 75(5):1691-700. PubMed ID: 5306498
    [No Abstract]   [Full Text] [Related]  

  • 12. [First clinical experiences with a new hypotensive substance in severe forms of hypertension].
    Bergström J; Bergquist-Poppen M; Bucht H
    Arzneimittelforschung; 1966 Dec; 16(12):1606-10. PubMed ID: 6014792
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experiences with a new antihypertensive agent].
    Lieb W; Ridders K
    Arzneimittelforschung; 1966 Dec; 16(12):1610-5. PubMed ID: 6014793
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long-term antihypertensive therapy with moxonidine (cynt) in patients with insulin-independent diabetes mellitus].
    Lazebnik LB; Malichenko SB; Serebrov AN
    Ter Arkh; 1997; 69(6):59-64. PubMed ID: 9297279
    [No Abstract]   [Full Text] [Related]  

  • 15. [Long-term clinical study and serial determination of urinary catecholamines using the new antihypertensive agent ST-155].
    Villalpando J; Skromme D; Chávez B; Serrano P
    Arch Inst Cardiol Mex; 1968; 38(6):841-50. PubMed ID: 5711376
    [No Abstract]   [Full Text] [Related]  

  • 16. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
    MacKay JH; Arcuri KE; Goldberg AI; Snapinn SM; Sweet CS
    Arch Intern Med; 1996 Feb; 156(3):278-85. PubMed ID: 8572837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure reduction with olmesartan in mild-to-moderate essential hypertension: a planned interim analysis of an open label sub-study in German patients.
    Böhm M; Ewald S;
    Curr Med Res Opin; 2006 Jul; 22(7):1375-80. PubMed ID: 16834836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of prolonged treatment with 2-(2,6-dichlorophenylamine)-2-imidazoline HCl on renal hemodynamics in arterial hypertension].
    Ludwig H
    Arzneimittelforschung; 1968 May; 18(5):600-4. PubMed ID: 5755891
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of an imidazoline derivative on arterial hypertension with or without associated toxemia].
    Delgado Urdapilleta J; Castro Carvajal F
    Ginecol Obstet Mex; 1969 Mar; 25(149):253-6. PubMed ID: 5780802
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension.
    Dahlöf B; Keller SE; Makris L; Goldberg AI; Sweet CS; Lim NY
    Am J Hypertens; 1995 Jun; 8(6):578-83. PubMed ID: 7662242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.